10 Year Financial Data of ViroPharma, Inc. (VPHM)

28.8 (1y: +22%)

Market Cap	1.87 B	P/E(ttm)	449.60
Enterprise Value	1.78 B	P/B	2.40

VPHM- NAS (USA)
ViroPharma, Inc.

Currently 1/5

Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$28.80

3 Severe Warning Signs 2 Medium Warning Signs

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	44.5	22.3	-8.4
EBITDA Growth (%)	0	12.2	-138
Free Cash Flow Growth (%)	0	-5.8	-97.7
Book Value Growth (%)	0	6.9	4.1

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	0.06	0.84	2.30	2.38	2.52	2.71	4.01	4.87	6.18	5.96	5.86	1.60	1.36	1.35	1.51	1.64
EBITDA per Share	-1.22	-0.41	1.63	1.49	1.52	1.06	0.80	2.70	2.90	0.99	-1.04	0.59	0.18	0.08	0.05	-1.35
Free Cashflow per Share	-1.36	-0.80	1.05	1.23	1.34	1.04	1.07	2.12	1.90	0.58	0.05	0.62	0.31	-0.01	-0.45	0.20
Earnings per Share ($)	-1.43	-0.73	2.02	0.95	1.21	0.83	-0.14	1.47	1.68	0.08	-1.20	0.26	-0.06	-0.07	-0.09	-0.98
Book Value per Share	-0.29	-0.98	5.68	5.86	6.14	7.71	9.69	9.89	10.12	10.55	10.74	10.32	12.35	11.57	10.74	10.74
Month End Stock Price	2.77	3.25	18.50	14.64	7.94	13.02	8.39	17.32	27.39	22.76	25.16	30.07	23.70	30.19	22.76	25.16
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	--	--	34.80	16.20	19.20	10.20	-1.50	14.10	15.80	0.70	-36.40	9.20	-2.00	-2.40	-2.80	-36.40
Return on Assets %	-27.80	-11.00	26.10	15.50	12.30	6.40	-1.00	9.80	10.50	0.50	-23.20	6.00	-1.20	-1.60	-2.00	-23.20
Return on Capital - Joel Greenblatt %	--	-136	266	713	552	162	37.70	315	248	32.30	-369	231	--	-30.80	-20.80	-369
Debt to Equity	-17.03	-7.28	0.30	--	0.50	0.38	0.19	0.16	0.17	0.21	0.23	0.18	0.18	0.20	0.21	0.23

Gross Margin %	100.00	92.30	86.40	88.60	95.60	96.20	87.00	86.00	85.30	74.60	72.10	76.40	73.90	76.30	71.60	72.10
Operating Margin %	-2,107	-53.60	66.60	59.10	56.80	33.90	10.30	48.20	40.80	7.80	-91.30	29.70	2.90	-4.60	-5.10	-91.30
Net Margin %	-2,292	-87.20	85.90	39.90	46.80	29.10	-3.60	28.60	25.80	1.30	-59.70	14.70	-4.40	-5.00	-5.30	-59.70

Days Sales Outstanding	20.20	142	41.00	28.00	42.30	34.50	48.50	36.50	52.70	63.50	49.60	42.50	52.50	51.10	63.60	49.60
Days Inventory	--	217	223	91.50	192	1,118	377	324	275	217	224	161	151	232	194	224
Inventory Turnover	--	1.70	1.60	4.00	1.90	0.30	1.00	1.10	1.30	1.70	0.40	0.60	0.60	0.40	0.50	0.40

Debt to Revenue	79.35	8.50	0.74	--	1.23	1.08	0.45	0.33	0.28	0.38	1.53	1.15	1.67	1.75	1.52	1.53
COGS to Revenue	--	0.08	0.14	0.11	0.04	0.04	0.13	0.14	0.15	0.25	0.28	0.24	0.26	0.24	0.28	0.28
Inventory to Revenue	--	0.05	0.08	0.03	0.02	0.12	0.13	0.12	0.11	0.15	0.69	0.42	0.43	0.60	0.61	0.69
Interest Exp. to Revenue %	-410	-41.27	-7.02	5.48	9.75	3.64	-3.63	-2.56	-2.20	-3.15	-3.21	-2.44	-3.57	-3.74	-3.20	-3.21

Asset Turnover	0.01	0.13	0.30	0.39	0.26	0.22	0.29	0.34	0.41	0.35	0.10	0.10	0.07	0.07	0.09	0.10
Buyback Ratio	0.20	1.40	-145	-16.30	-0.70	-0.80	3.40	-2.80	-10.40	-213	2.50	-27.80	9.30	70.70	49.60	2.50
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	1.61	22.39	132	167	204	232	310	439	544	428	399	136	94.64	91.00	106	107
Cost of Goods Sold	--	1.72	18.03	18.98	8.93	8.87	40.21	61.29	79.98	109	106	32.08	24.72	21.55	30.20	29.86
Gross Profit	1.61	20.67	114	148	195	223	270	378	464	319	293	104	69.92	69.45	76.29	77.29

Selling, General, &Admin. Expense	12.54	15.64	10.48	24.56	37.05	65.42	89.32	95.66	128	174	179	37.95	40.88	44.29	50.98	42.72
Research &Development	23.04	16.39	10.61	19.16	35.87	66.28	52.08	39.61	66.48	67.71	69.51	15.40	16.62	16.55	19.14	17.20
Earnings Before DDA	-31.68	-10.83	93.68	105	123	90.64	61.79	243	256	71.16	-66.66	49.87	12.25	5.35	3.87	-88.12

Depreciation, Depletion and Amortization	2.29	1.18	5.54	6.17	6.92	11.99	29.66	31.21	33.47	37.82	38.00	9.56	9.48	9.52	9.26	9.74

Operating Income	-33.97	-12.01	88.15	98.81	116	78.66	32.13	212	222	33.34	-105	40.31	2.77	-4.17	-5.39	-97.86
Interest Income/Expense	-6.61	-9.24	-9.30	9.17	19.87	8.44	-11.26	-11.24	-11.99	-13.50	-13.63	-3.31	-3.38	-3.40	-3.41	-3.44
Net Income	-36.94	-19.53	114	66.67	95.35	67.62	-11.08	126	141	5.61	-78.38	19.99	-4.20	-4.57	-5.61	-64.00

Earnings per Share ($)	-1.43	-0.73	2.02	0.95	1.21	0.83	-0.14	1.47	1.68	0.08	-1.20	0.26	-0.06	-0.07	-0.09	-0.98
Total Shares Outstanding	25.92	26.58	57.61	70.34	80.89	85.71	77.42	90.08	88.08	71.76	65.21	85.03	69.39	67.61	70.49	65.21
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	121	35.18	233	255	584	276	332	505	460	247	261	473	472	304	247	261
Accounts Receivable	0.09	8.71	14.89	12.82	23.62	21.93	41.24	43.88	78.53	74.40	58.39	63.39	54.61	51.06	74.40	58.39
Inventory	--	1.02	11.00	4.76	4.70	27.17	41.58	54.39	60.32	64.38	73.41	56.70	41.09	54.87	64.38	73.41
Other Current Assets	2.39	10.66	15.53	11.25	10.12	35.94	31.87	29.70	37.25	67.78	64.23	41.94	54.08	45.88	67.78	64.23
Total Current Assets	124	55.57	275	284	623	361	446	633	636	453	457	635	622	455	453	457

Property, Plant and Equipment	7.21	1.50	1.56	2.83	10.89	6.85	10.51	11.47	11.98	10.85	10.80	11.55	11.13	11.07	10.85	10.80
Intangible Assets	--	116	122	123	123	670	619	626	662	714	600	656	730	723	714	600
Other Long Term Assets	2.00	4.47	37.45	19.96	19.90	16.32	9.07	17.03	27.04	41.39	40.40	27.35	38.94	52.27	41.39	40.40
Total Assets	133	178	436	430	776	1,054	1,084	1,288	1,337	1,220	1,108	1,331	1,401	1,241	1,220	1,108

Accounts Payable	7.45	12.10	9.26	13.83	20.70	43.47	39.99	61.15	84.36	42.26	92.57	95.93	189	100	42.26	92.57
Current Portion of Long-Term Debt	0.01	--	98.32	--	--	--	--	--	--	--	--	--	--	--	--	--
Other Current Liabilities	3.08	0.98	0.58	3.97	7.67	--	--	10.97	14.30	71.77	8.09	7.93	7.73	8.04	71.77	8.09
Total Current Liabilities	10.53	13.08	108	17.80	28.37	43.47	39.99	72.12	98.65	114	101	104	197	108	114	101

Long-Term Debt	128	190	--	--	250	250	139	146	153	162	164	155	158	160	162	164
Other Long-Term Liabilities	1.92	0.56	0.39	--	1.13	99.19	155	179	194	187	143	194	190	191	187	143
Total Liabilities	140	204	109	17.80	280	393	334	396	446	463	407	453	544	459	463	407

Common Stock	0.05	0.05	0.14	0.14	0.14	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16
Retained Earnings	-258	-277	-163	-96.73	-1.38	66.24	48.25	174	315	320	256	335	330	326	320	256
Additional Paid-In Capital	250	251	491	508	498	595	701	717	750	790	798	765	771	780	790	798
Treasury Stock	--	--	--	--	--	--	--	--	-170	-350	-350	-220	-241	-322	-350	-350
Total Equity	-7.51	-26.14	327	412	497	661	750	891	891	757	701	877	857	782	757	701
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	-36.94	-19.53	114	66.67	95.35	67.62	-11.08	126	141	5.61	-78.38	19.99	-4.20	-4.57	-5.61	-64.00
Depreciation, Depletion and Amortization	2.29	1.18	5.54	6.17	6.92	11.99	29.66	31.21	33.47	37.82	38.00	9.56	9.48	9.52	9.26	9.74
Cash Flow from Others	0.45	-1.85	-47.74	22.18	20.59	11.83	66.20	36.70	-3.40	-0.41	43.95	23.76	16.29	-5.03	-35.43	68.12
Cash Flow from Operations	-34.20	-20.21	71.50	95.02	123	91.44	84.78	194	171	43.02	3.57	53.31	21.57	-0.08	-31.79	13.86

Investment for Property, Plant & Equipement	-0.98	-1.01	-10.92	-8.42	-14.82	-2.53	-1.93	-2.81	-3.01	-1.33	-1.92	-0.27	-0.32	-0.59	-0.16	-0.86
Cash Flow from Acquisitions	--	-118	--	--	--	-380	--	-13.15	-32.04	-92.27	-92.27	--	--	-91.40	-0.87	--
Cash Flow from Investing	33.34	-28.70	8.58	-209	-216	15.44	-8.93	-102	-101	-38.05	-47.30	17.89	-5.78	-75.45	25.29	8.64

Net Issuance of Stock	0.08	0.28	165	10.86	-22.54	0.54	0.38	3.54	-155	-168	-122	-44.44	-21.14	-77.15	-25.66	1.61
Net Issuance of Debt	-0.12	58.66	-35.94	-79.60	242	-12.06	-21.15	-1.58	-0.29	--	--	--	--	--	--	--
Other Financing	-2.13	0.00	--	2.05	2.18	1.45	0.32	1.60	-7.95	7.12	2.71	4.83	0.01	0.58	1.70	0.42
Cash Flow from Financing	-2.16	58.94	129	-66.69	221	-10.07	-20.45	3.57	-163	-161	-120	-39.61	-21.13	-76.56	-23.96	2.02

Net Change in Cash	-3.02	10.02	209	-181	128	96.15	55.83	95.06	-95.38	-156	-164	32.29	-6.43	-151	-30.21	23.68

Free Cash Flow	-35.19	-21.22	60.58	86.60	108	88.91	82.85	191	168	41.68	1.65	53.04	21.25	-0.66	-31.95	13.01
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

VPHM Quarterly/Annuals Reports

VPHM: 10-Q - VIROPHARMA INC (0000946840) (Filer): (10-Q) - 2012-10-25
VPHM: 10-Q - VIROPHARMA INC (0000946840) (Filer): (10-Q) - 2012-08-09
VPHM: 10-Q - VIROPHARMA INC (0000946840) (Filer): (10-Q) - 2012-05-01
VPHM: 10-K - VIROPHARMA INC (0000946840) (Filer): (10-K) - 2012-02-28
VPHM: 10-Q - VIROPHARMA INC (0000946840) (Filer): (10-Q) - 2011-10-27

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

VPHM Quarterly/Annuals Reports